Craig Matturro
InvestorPrincipal at 1315 Capital
About
Craig Matturro joined 1315 Capital in 2016, having previously spent two years as an analyst in the investment banking group at Leerink Partners, where he worked on M&A and private placement engagements for healthcare companies. While at 1315 Capital he served on secondment as Director of Business Development for portfolio company JDS Therapeutics, leading the divestiture of its Nutrition21 division and the acquisition of nutraceutical assets by its Bonafide Health division. He holds a BSc in Business Administration with a concentration in Finance and a minor in Engineering Studies from Carnegie Mellon University.
Invests in
BiotechHealthtechMedical Devices
Deals · 1
Spineology IncBoard seat
via 1315 Capital · filed Jun 2026 · $14.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
